Research & Clinical Studies

Medicine is constantly evolving, and Indiana University Health Neuroscience is committed to continually push the boundaries of research to offer even better care options for tomorrow’s patients. By integrating a research facility into the premier IU Health Neuroscience Center, people will have easier, faster access to clinical trials and breakthrough treatments. As one of the nation’s largest neuroscience research facilities, our doctors, researchers, and scientists lead and participate in a variety of studies on neurological disorders, including stroke, brain injury, brain tumors, spinal cord injury and more.

Leading the way is the Stark Neurosciences Research Institute (SNRI) at Indiana University School of Medicine. SNRI is an internationally renowned program with 59 investigators dedicated to finding the next groundbreaking treatments for patients with neurological conditions. In addition, our longtime affiliation with IU School of Medicine—the nation's second-largest medical school—provides access to a rigorous research program and ensures you the benefit of early access to breakthrough findings.

Research breakthroughs

Some of the recent groundbreaking research trials conducted at IU Health Neuroscience include:

  • The first approved oral medication for relapsing-remitting multiple sclerosis
  • Non-contact boxing as a treatment for Parkinson’s disease
  • Various drugs to improve memory in patients with Alzheimer’s disease
  • Deep brain stimulation for patients with difficult to manage seizures
  • The NeuroPace Responsive Neurostimulator System, an impact that helps detect seizure patterns and stop them before they arise
  • The use of the Gamma Knife radiosurgery versus temporal lobectomy for epilepsy patients who do not respond to medication

IU Health Neuroscience is a member of the Indiana Clinical and Translational Sciences Institute (CTSI) in an effort to communicate relevant breakthroughs and translate these findings to clinical trials, thus bringing new technologies even faster to patients. 

For more information on clinical trials conducted at IU Health Neuroscience, please visit http://www.clinicaltrials.gov.

Indiana Alzheimer Disease Center (IADC)

IU Health Neuroscience is home to Indiana's only Alzheimer Disease Center, one of only 29 such centers in the country. Here, researchers look for ways to improve treatment for people living with Alzheimer's and conduct clinical studies that could lead to a cure for the disease. IADC is also leading the way in neuroimaging research. Researchers use MRI and PET studies to examine the brains of Alzheimer's patients and study the progression of the disease.

Research at work

For 25 years, Stephanie's life was ruled by epilepsy. She endured an average of 16 seizures each day. And because she never knew when the next one might strike, she was unable to participate in everyday activities. She was literally held captive by her condition. That is until she became one of the first Hoosier recipients of the NeuroPace RNS System. The small, implanted device delivers mild electrical charges to the section of the brain where her seizures originate. Programmed to detect subtle changes in her brain activity, the device sends its electrical charges before the seizure can spread and before symptoms appear. Stephanie has had the device for more than five years and her seizures are down to approximately one every other day. Thanks to the advanced epilepsy care at Indiana University Health, she is finally enjoying the activities she previously only dreamed of.